Live Quote · NASDAQPLYXHealthcare· Biotechnology

Polaryx Therapeutics, Inc. Common Stock

$1.33▼ 11.92%($-0.18)
MKT CAP $66.30MNEXT EARNINGS Feb 11, 2027
50%
Bullish
TickerSpark Score
42/100
▌ Weak
60
Valuation
20
Profitability
15
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PLYX research report →

Analyst Price Target
$6.50+388.7% vs. today

Range $6 – $7

Price Chart

-96.20% · this period
$35.00$18.16$1.33Feb 02Jun 30Nov 20
52-Week Range0% of range
Low
$1.30
Current
$1.33
High
$48.91